Hospital
MCHS Hospitals INC
MCHS Hospitals INC was paid $7.36M by Medicaid between Sep 2018 and Dec 2024, across 120 billing codes. Its largest line is 99283, emergency room visit (moderate) — 26% of everything it billed.
33Billing provider infoMCHS HOSPITALS INC
LADYSMITH, WI 54848
LADYSMITH, WI 54848
33aNPI1952890873assigned 05/07/2018
33bProvider typeCritical Access Hospital
28Total paid$7.36M
24GClaims159,520
24DCodes billed120
24AFirst – last monthSep 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Wisconsin
Rank by total paid#16 of 48
Median peer was paid$4.30M
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MUNSON, JOLYN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,537 | $233K | |
| 2019 | 20,854 | $989K | |
| 2020 | 23,836 | $955K | |
| 2021 | 28,457 | $1.18M | |
| 2022 | 26,274 | $1.32M | |
| 2023 | 28,632 | $1.41M | |
| 2024incomplete | 24,930 | $1.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 13,199 | 10,442 | $1.92M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 8,258 | 6,118 | $919K |
| 96361 | Intravenous infusion, hydration; each additional hour | 11% | 2,372 | 1,627 | $819K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.1% | 2,916 | 2,498 | $451K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.8% | 5,155 | 4,127 | $425K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.7% | 3,625 | 2,459 | $422K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.0% | 1,180 | 1,027 | $296K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.5% | 1,768 | 1,121 | $259K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.5% | 1,097 | 948 | $256K |
| 41899 | Unlisted procedure, dentoalveolar structures | 3.3% | 188 | 168 | $240K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.0% | 1,895 | 1,462 | $219K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.1% | 1,917 | 1,696 | $154K |
108 more codes
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 1.0% | 896 | $76K |
| G0383 | Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 577 | $63K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,695 | $56K |
| 80053 | Comprehensive metabolic panel | <1% | 7,847 | $51K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,196 | $47K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,051 | $45K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,509 | $37K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 592 | $34K |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | <1% | 37 | $31K |
| 80061 | Lipid panel | <1% | 2,403 | $27K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,749 | $27K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,855 | $23K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,291 | $22K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 131 | $22K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 984 | $22K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,554 | $21K |
| 83880 | <1% | 1,508 | $21K | |
| 84484 | <1% | 3,849 | $19K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 311 | $18K |
| 87634 | <1% | 432 | $18K | |
| 80050 | General health panel | <1% | 977 | $14K |
| 81025 | <1% | 1,668 | $13K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,267 | $13K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,256 | $12K |
| 81001 | <1% | 5,620 | $12K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 92 | $12K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,428 | $11K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 94 | $11K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 162 | $11K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 282 | $11K |
| 85610 | <1% | 2,628 | $11K | |
| 83605 | <1% | 2,124 | $10K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 393 | $10K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,562 | $9K |
| 11721 | <1% | 298 | $8K | |
| 83690 | <1% | 1,795 | $8K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 28 | $8K |
| 83735 | <1% | 2,547 | $7K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 56 | $7K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 34 | $7K |
| 84145 | <1% | 707 | $6K | |
| 73630 | <1% | 285 | $6K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,521 | $6K |
| 86140 | <1% | 1,715 | $5K | |
| 82728 | <1% | 459 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 14,366 | $4K |
| G0384 | Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 35 | $4K |
| G0381 | Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 66 | $4K |
| 36592 | <1% | 1,990 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 33 | $4K |
| 85027 | <1% | 817 | $4K | |
| 85379 | <1% | 783 | $4K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,285 | $3K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 16 | $3K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 82 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 15 | $2K |
| 73562 | <1% | 105 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 27 | $1K |
| 85730 | <1% | 613 | $1K | |
| 87186 | <1% | 225 | $1K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 56 | $1K |
| 87088 | <1% | 205 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 26 | $849.98 |
| 83550 | <1% | 114 | $849.63 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 12 | $848.85 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 25 | $813.72 |
| 83540 | <1% | 140 | $783.93 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 66 | $763.12 |
| 87040 | <1% | 250 | $749.89 | |
| 83615 | <1% | 250 | $724.40 | |
| 82150 | <1% | 151 | $670.36 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 32 | $624.58 |
| 84153 | <1% | 41 | $581.71 | |
| 73610 | <1% | 38 | $532.40 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,029 | $425.24 |
| 81003 | <1% | 206 | $416.96 | |
| 85652 | <1% | 216 | $404.69 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 13 | $402.12 |
| 86803 | <1% | 28 | $402.00 | |
| 80306 | <1% | 29 | $314.45 | |
| 82550 | <1% | 134 | $302.63 | |
| 73030 | <1% | 15 | $283.20 | |
| 82570 | <1% | 70 | $264.02 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,352 | $234.01 |
| 82962 | <1% | 236 | $188.70 | |
| 86618 | <1% | 14 | $176.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,976 | $155.56 |
| 80305 | <1% | 14 | $154.01 | |
| 87077 | <1% | 45 | $150.30 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 14 | $125.86 |
| 85018 | <1% | 61 | $123.84 | |
| 82043 | <1% | 29 | $119.94 | |
| 84439 | <1% | 16 | $102.52 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 485 | $83.93 |
| 87081 | <1% | 24 | $82.00 | |
| 82977 | <1% | 13 | $76.17 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,309 | $64.52 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,333 | $61.18 |
| J2704 | Injection, propofol, 10 mg | <1% | 519 | $36.13 |
| J3490 | Unclassified drugs | <1% | 161 | $26.66 |
| 96376 | <1% | 190 | $23.45 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 678 | $3.58 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 609 | $1.67 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 147 | $0.23 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 585 | $0.14 |
| A9270 | Non-covered item or service | 0% | 796 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 259 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMUNSON, JOLYN (VP REVENUE CYCLE OPERATIONS)
Parent organizationMARSHFIELD CLINIC HEALTH SYSTEM INC
| Provider | Location | Paid |
|---|---|---|
| MCHS Hospitals INC | Marshfield, WI | $45.31M |
| Marshfield Clinic INC | Marshfield, WI | $19.61M |
| MCHS Hospitals INC | Eau Claire, WI | $12.41M |
| MCHS Hospitals INC | Marshfield, WI | $11.82M |
| Beaver Dam Community Hospitals INC | Beaver Dam, WI | $10.58M |
| Dickinson County Healthcare System | Iron Mountain, MI | $10.23M |
| MCHS Hospitals INC | Weston, WI | $6.40M |
| MCHS Hospitals INC | Eau Claire, WI | $4.14M |
| MCHS Hospitals INC | Minocqua, WI | $2.90M |
| Dickinson County Healthcare System | Iron Mountain, MI | $2.44M |
| Dickinson County Healthcare System | Iron Mountain, MI | $2.29M |
| MCHS Hospitals INC | Wausau, WI | $1.84M |
| MCHS Hospitals INC | Weston, WI | $1.22M |
| MCHS Hospitals INC | Minocqua, WI | $1.16M |
| MCHS Hospitals INC | Marshfield, WI | $988K |
| MCHS Hospitals INC | Ladysmith, WI | $867K |
| Beaver Dam Community Hospitals INC | Beaver Dam, WI | $847K |
| Dickinson County Healthcare System | Iron Mountain, MI | $648K |
| MCHS Hospitals INC | Marshfield, WI | $563K |
| MCHS Hospitals INC | Minocqua, WI | $338K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.